FAQ

Yumex

Known as: Humex, Jumex 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2016
012319832016

Related topics

Related topics

1 relation

Broader (1)

Selegiline

Related mentions per year

Related mentions per year

1970-2018
197019801990200020102020
Yumex
Selegiline

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Comparison of Hydrolyzed Protein Baits and Various Grape Juice Products as Attractants for Anastrepha Fruit Flies (Diptera: Tephritidae).
Mexican fruit flies, Anastrepha ludens (Loew; Diptera: Tephritidae), have traditionally been trapped in citrus orchards in Mexico… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson’s Disease with Neuroprotective Potential
Rasagiline (Azilect) is a highly selective and potent propargylamine inhibitor of monoamine oxidase (MAO) type B. Like other… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2010
2010
Humanization of a mouse monoclonal antibody directed against a cell surface-exposed epitope of membrane-associated heat shock protein 70 (Hsp70).
The translocation of heat shock protein 70 (mHsp70) into the plasma membrane has been found to be associated with various cancers… (More)
Is this relevant?
Review
2009
Review
2009
[Slowing the age-induced decline of brain function with prophylactic use of (-)-deprenyl (Selegiline, Jumex). Current international view and conclusions 25 years after the Knoll's proposal].
Due primarily to developments in immunology, chemotherapy and hygiene the estimated life expectancy at birth increased during the… (More)
Is this relevant?
Review
1997
Review
1997
[History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
(-)Deprenyl (Selegiline, Jumex, Eldepryl, Movergan), a close structural relative of phenylethylamine (PEA), is a drug with a… (More)
Is this relevant?
1993
1993
[ Selegiline (Jumex) in the treatment of narcolepsy].
 
Is this relevant?
Review
1992
Review
1992
(-)Deprenyl-medication: a strategy to modulate the age-related decline of the striatal dopaminergic system.
(-)Deprenyl (Selegiline, Jumex, Eldepryl, Movergan), a close structural relative to phenylethylamine (PEA), is a drug with a… (More)
Is this relevant?
1987
1987
R-(-)-deprenyl as a possible protective agent in Parkinson's disease.
The selective monoamine oxidase (MAO) B inhibitor L-deprenyl (Eldepryl, Jumex, Movergan, Selegiline) has gained acceptance as a… (More)
Is this relevant?
1987
1987
Brief information on an early phase-II study with deprenyl in demented patients.
Eleven elderly female patients (73-88 yrs) suffering from senile dementia of Alzheimer type (7 cases) and from multi-infarct… (More)
Is this relevant?
1986
1986
[Therapeutic strategies and tactics in parkinsonism].
The main medication is Madopar and Sinemet; various additives are able to reduce the Dopa dose in order to avoid various side… (More)
Is this relevant?